FDA adds Darzalex Faspro to combo therapy for newly diagnosed MM
The U.S. Food and Drug Administration (FDA) has approved…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe U.S. Food and Drug Administration (FDA) has approved…
A blood test measuring numbers of lymphocytes, a type…
A committee of the European Medicines Agency (EMA) has…
Through its Myeloma Investment Fund, the Multiple Myeloma…
The Leukemia & Lymphoma Society (LLS) is once…
Researchers in Germany have identified proteins that could help…